Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

New discovery enhances feasibility of cardiovascular gene therapy

Oct. 8, 1997

FDA approves irbesartan for marketing

Oct. 8, 1997

Millennium and Lilly extend cardiovascular research collaboration

Oct. 7, 1997

HMR and Andrx agree to stipulation in Cardizem CD patent lawsuit

Oct. 7, 1997

Cytokine synthesis inhibitor protects against polymicrobial sepsis in animal model

Oct. 6, 1997

Novel class III antiarrhythmic agents described by Merck & Co.

Oct. 6, 1997

Cypros to start phase III trial for CABG

Oct. 3, 1997

Focus on benzoyl guanidines as Na+/H+-exchange inhibitors

Oct. 2, 1997

Cytel reports encouraging results from Cylexin phase I/II trial

Oct. 2, 1997

Single- and multiple-dose clinical studies reported for SL-91.0102

Oct. 1, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...